PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial
Frédéric Dumont, Vahan Kepenekian, Christophe Passot, Anne-Cécile Ezanno-Manasterski, Marc Pocard, Jean-Luc, Raoul, and others
European Journal of Surgical OncologyVol. 50Issue 9Published online: June 4, 2024
The ISSPP PIPAC database: design, process, access, and first interim analysis
Mortensen MB, Glehen O, Horvath P, Hübner M, Hyung-Ho K, Königsrainer A, Pocard M, Reymond MA, So J, Fristrup CW. Pleura Peritoneum. 2021 Apr 22;6(3):91-97. doi: 10.1515/pp-2021-0108. eCollection 2021 Sep. PMID: 34676282
Free PMC article.
Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).
Nadiradze G, Horvath P, Sautkin Y, Archid R, Weinreich FJ, Königsrainer A, Reymond MA. Cancers (Basel). 2019 Dec 20;12(1):34. doi: 10.3390/cancers12010034. PMID: 31877647
Free PMC article. Review.
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer.
Rezniczek GA, Giger-Pabst U, Thaher O, Tempfer CB. BMC Cancer. 2020 Nov 19;20(1):1122. doi: 10.1186/s12885-020-07627-1. PMID: 33213407 Free PMC article.
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma.Giger-Pabst U, Demtröder C, Falkenstein TA, Ouaissi M, Götze TO, Rezniczek GA, Tempfer CB. BMC Cancer. 2018 Apr 18;18(1):442. doi: 10.1186/s12885-018-4363-0. PMID: 29669524
Free PMC article.
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients.
Ellebæk SB, Graversen M, Detlefsen S, Lundell L, Fristrup CW, Pfeiffer P, Mortensen MB. Pleura Peritoneum. 2020 May 15;5(2):20200109. doi: 10.1515/pp-2020-0109. eCollection 2020 Jun 1. PMID: 32566727
Free PMC article.
PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.
Kim G, Tan HL, Sundar R, Lieske B, Chee CE, Ho J, Shabbir A, Babak MV, Ang WH, Goh BC, Yong WP, Wang L, So JBY. Clin Cancer Res. 2021 Apr 1;27(7):1875-1881. doi: 10.1158/1078-0432.CCR-20-2152. Epub 2020 Nov 4. PMID: 33148667
Free article.
PIPAC = pressurized intraperitoneal aerosol chemotherapy
PIPAC: 8 key points for a good practice with video.
Mariano G, Pocard M, Eveno C.
J Visc Surg. 2019 Apr;156(2):169-171.
Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy.
Teixeira Farinha H, Grass F, Labgaa I, Pache B, Demartines N, Hübner M.
J Cancer. 2018 Jan 1;9(1):13-20.
Free PMC Article
Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study.
Teixeira Farinha H, Grass F, Kefleyesus A, Achtari C, Romain B, Montemurro M, Demartines N, Hübner M.
Gastroenterol Res Pract. 2017;2017:4596176.
Free PMC Article
Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis.
Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hübner M.
Br J Surg. 2017 May;104(6):669-678.
Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications.
Alyami M, Hübner M, Grass F, Bakrin N, Villeneuve L, Laplace N, Passot G, Glehen O, Kepenekian V.
Lancet Oncol. 2019 Jul;20(7):e368-e377.
Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study.
Sgarbura O, Hübner M, Alyami M, Eveno C, Gagnière J, Pache B, Pocard M, Bakrin N, Quénet F.
Eur J Surg Oncol. 2019 Dec;45(12):2386-2391.
Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human study.
Van De Sande L, Graversen M, Hubner M, Pocard M, Reymond M, Vaira M, Cosyns S, Willaert W, Ceelen W.
Pleura Peritoneum. 2018 Jun 8;3(2):20180112.
Free PMC Article
Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).
Nadiradze G, Horvath P, Sautkin Y, Archid R, Weinreich FJ, Königsrainer A, Reymond MA.
Cancers (Basel). 2019 Dec 20;12(1). pii: E34. doi: 10.3390/cancers12010034. Review.
Free Article
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Girshally R, Demtröder C, Albayrak N, Zieren J, Tempfer C, Reymond MA.
World J Surg Oncol. 2016 Sep 27;14(1):253.
Free PMC Article
